₅Brent R Copp

Summary for 2004 [at-glance overview of Brent R Copp work for the selected year as suggested by data mining algorithms]

This is an Authoratory overview of author Brent R Copp. According to available data, in 2004 Brent R Copp published at least 5 articles. This work was completed in collaboration with several authors including Barry, Clifton E and Blunt, John W. Many other authors have collaborated with Brent R Copp as well. There is no information about the funding or the grants awarded to support this work.

Analysis of the article abstracts and the titles suggests that Brent R Copp professional interests are focused around "marine natural products", "zealand ascidian pseudodistoma" and "ascidian pseudodistoma cereum". These might also be referred to as "marine natural", "cleavable complex" or "natural products". Statistical analysis shows that Brent R Copp's writing is likely to contains terms "natural", "marine", "zebrafish", "agents", "action" and "mechanism".

Unfortunately, there is not enough information to establish Brent R Copp affiliation. Luckily, several email addresses are on file.

EN FR ES RU

Inaccurate information, needs improvement

make correction leave comment ask question

Images [images we found on the Internet for Brent R Copp]

Do you know Brent R Copp who matches the profile above? Click the photo and let us know!

Alternative names (0) [other authors with names similar to Brent R Copp]

none

Year 2004 Charts [Brent R Copp frequent coauthors and the most common unique vocabulary terms for the selected year]

Historical Performance Charts [graphical overview of Brent R Copp publication and funding history for the range of years]

Emails (3) [email addresses extracted from Brent R Copp affiliations]

hidden to prevent spam, click here to reveal

Brent R Copp Coauthors (17) [all coauthors with the number of joint publications]

1

1

1

1

1

1

1

1

1

1

1

1

1

1

1

1

1

Other [context-specific ads]

Affiliations (5) [condensed summary of the Brent R Copp affiliations, the leading number and the color conveys importance]

₁School of Biological Sciences, University of Auckland, Private Bag 92019, Auckland 1001, New Zealand.
₁Department of Pharmacology and Toxicology, University of Utah, Salt Lake City, UT 84112, USA.
₁Tuberculosis Research Section, NIAID, National Institutes of Health, Rockville, Maryland 20852, USA.
₁Department of Chemistry, University of Canterbury, Christchurch, New Zealand.
₁Department of Chemistry, The University of Auckland, Private Bag 92019, Auckland, New Zealand.

Key Opinion Leader In [Brent R Copp is considered a key opinion leader in any keyword where the rank of 5 is achieved, the leading number before the keyword shows the author's rank as compared to all other authors]

no keywords assigned

Keywords (32) [keywords assigned to Brent R Copp articles by PubMed, the leading number and the color conveys importance]

₄Animals | ₂Urochordata | ₂Enzyme Inhibitors | ₂Oligonucleotide Array Sequence Analysis | ₁Ethambutol | ₁Mycobacterium tuberculosis | ₁Algae | ₁Antipsychotic Agents | ₁Marine Biology | ₁Bryozoa | ₁Cricetinae | ₁Biological Products | ₁DNA Topoisomerases, Type I | ₁Azoles | ₁Electron Transport | ₁Drug Design | ₁Molecular Structure | ₁Antineoplastic Agents | ₁Intercalating Agents | ₁Dose-Response Relationship, Drug | ₁Cell Line, Tumor | ₁Proteomics | ₁DNA Damage | ₁Fluoroquinolones | ₁Enzyme Stability | ₁DNA Gyrase | ₁Cell Wall | ₁Humans | ₁DNA Topoisomerases, Type II | ₁Zebrafish | ₁Phenanthrolines | ₁Antitubercular Agents

Brent R Copp Unique Vocabulary (96) [single words, word pairs and phrases obtained by analysis of abstracts and titles, the leading number and the color conveys importance; Brent R Copp might be a good expert witness on these terms]

₈natural | ₇marine | ₆zebrafish | ₅agents | ₅action | ₅mechanism | ₅products | ₅cleavable | ₅activity | ₅complex | ₅drug | ₄high-throughput | ₄gene | ₄analysis | ₄can | ₄pyridoacridines | ₄ak37 | ₄drugs | ₃pyridoacridine | ₃clusters | ₃stabilizing | ₃ii | ₃topoisomerase | ₃dna-topo | ₃pseudodistoma | ₃cereum | ₃ascidian | ₃zealand | ₃3-dimethyl-8-oxoisoguanine | ₃purine | ₃capable | ₃metabolic
₆marine natural | ₅cleavable complex | ₅natural products | ₃ascidian pseudodistoma | ₃pseudodistoma cereum | ₃zealand ascidian | ₃mechanism action | ₃mycobacterium tuberculosis | ₂natural product | ₂capable stabilizing | ₂dna-topo cleavable | ₂ak37 pyridoacridine | ₂3-dimethyl-8-oxoisoguanine purine | ₂gene clusters | ₂described capable | ₂topoisomerase cleavable | ₂data set | ₂drug discovery | ₂pyridoacridine described | ₂topo ii | ₂stabilizing topoisomerase | ₂purine zealand | ₂tuberculosis inhibitors | ₂novel insights | ₂present future | ₂high-throughput screens | ₂screens present | ₂future using | ₂technology high-throughput | ₂transcriptional responses | ₂using zebrafish | ₂insights drug
₄marine natural products | ₃zealand ascidian pseudodistoma | ₃ascidian pseudodistoma cereum | ₂stabilizing topoisomerase cleavable | ₂capable stabilizing topoisomerase | ₂dna-topo cleavable complex | ₂pyridoacridine described capable | ₂described capable stabilizing | ₂topoisomerase cleavable complex | ₂ak37 pyridoacridine described | ₂3-dimethyl-8-oxoisoguanine purine zealand | ₂marine natural product | ₂purine zealand ascidian | ₂high-throughput screens present | ₂inhibitors metabolism novel | ₂tuberculosis inhibitors metabolism | ₂mycobacterium tuberculosis inhibitors | ₂metabolism novel insights | ₂technology high-throughput screens | ₂future using zebrafish | ₂transcriptional responses mycobacterium | ₂responses mycobacterium tuberculosis | ₂insights drug mechanisms | ₂drug mechanisms action | ₂novel insights drug | ₂present future using | ₂screens present future | ₁activity human topo | ₁treated small molecules | ₁planar structures found | ₁capable dna intercalation | ₁cleavable complex synthetic

Reader's Comments (0) [comments posted by readers of Brent R Copp profile]